Table 5.
Seventeen subjects, comparison of clinical symptom scores and sub-items between ketamine and placebo condition with repeated measure t-tests. 5D-ASC subitem scores were divided by 10 for better visualization.
| Parameter | Placebo |
Ketamine |
T | P |
|---|---|---|---|---|
| mean (SD) | mean (SD) | |||
| PANSS sum | 0 (0) | 41.71 (19.40) | 8.6 | <0.0001 |
| PANSS positive | 0 (0) | 10.29 (6.65) | 6.19 | <0.0001 |
| PANSS negative | 0 (0) | 8 (4.98) | 6.42 | <0.0001 |
| OBN | 1.88 (5.10) | 104.8 (56.31) | 7.47 | <0.0001 |
| DED | 2.43 (5.11) | 79.59 (47.22) | 5.99 | <0.0001 |
| VRS | 1.60 (2.93) | 55.56 (41.07) | 4.49 | <0.0001 |
| AUA | 1.25 (2.39) | 41.23 (39.30) | 4.32 | <0.0001 |
| VIR | 4.14 (7.54) | 60.96 (25.76) | 5.19 | <0.0001 |
Abbreviations: “oceanic boundlessness” (OBN), “dread of ego dissolution” (DED), “visionary restructuralization” (VRS), “auditory alterations” (AUA) and “vigilance reduction” (VIR).